Rays update on Griffin Jax after right elbow discomfort leads to IL stint

Tampa Bay Rays manager Kevin Cash said he received a “very good update” on starter Griffin Jax after Jax was placed on the 15-day injured list Sunday with right elbow discomfort. Ahead of the Rays’ Tuesday game against the Oakland Athletics at Sutter Health Park, Cash reported that Jax received an injection and that, if everything progresses as hoped, he expects to miss only the minimum required time.

The timing of the IL move puts immediate rotation pressure on Tampa Bay, especially with a road trip environment and a start scheduled just days after the injury designation. For the Rays, the key detail is not only that the ailment is being treated promptly, but that the plan appears to be a short stint rather than a longer rehab window.

In the team’s account, Cash framed the injection and the medical follow-up as the turning point in the day’s information flow, suggesting the elbow issue is being handled with caution while still holding out hope for a relatively quick return. Jax’s status, however, remains contingent on how the elbow responds over the duration of the IL period.

Jax’s situation also matters because Tampa Bay has been managing starters in a way that balances performance with availability, particularly late in the season when rotation consistency is a differentiator. If the right elbow responds well and he stays on track for the minimum IL stay, the Rays can limit disruption and preserve the rhythm of their pitching staff.

Against that backdrop, Tuesday’s game at Sutter Health Park takes on extra importance as a practical measure of what Tampa Bay’s rotation will look like in Jax’s absence. Even if the Rays remain optimistic about Jax’s timeline, the immediate weeks are when depth and bullpen usage can quietly shape outcomes.

For Athletics fans, the matchup is also a reminder that starting pitching decisions can change quickly when injuries occur. Tampa Bay’s ability to keep Jax from drifting into a longer rehab path will be watched closely, because it determines whether the Rays get the same starter-backfill strategy they planned or need to adjust further.

The Rays’ next checkpoint will be how Jax progresses through the rest of his IL timeline after the injection. If he can return as expected, Tampa Bay’s rotation stability could improve quickly. If soreness lingers, the Rays may need to rethink short-term innings planning and sequencing while they search for an alternative answer in the rotation.